BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 11426459)

  • 1. Subtle radiographic findings of achondroplasia in patients with Crouzon syndrome with acanthosis nigricans due to an Ala391Glu substitution in FGFR3.
    Schweitzer DN; Graham JM; Lachman RS; Jabs EW; Okajima K; Przylepa KA; Shanske A; Chen K; Neidich JA; Wilcox WR
    Am J Med Genet; 2001 Jan; 98(1):75-91. PubMed ID: 11426459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibroblast growth factor receptor 3 (FGFR3) transmembrane mutation in Crouzon syndrome with acanthosis nigricans.
    Meyers GA; Orlow SJ; Munro IR; Przylepa KA; Jabs EW
    Nat Genet; 1995 Dec; 11(4):462-4. PubMed ID: 7493034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The molecular and genetic basis of fibroblast growth factor receptor 3 disorders: the achondroplasia family of skeletal dysplasias, Muenke craniosynostosis, and Crouzon syndrome with acanthosis nigricans.
    Vajo Z; Francomano CA; Wilkin DJ
    Endocr Rev; 2000 Feb; 21(1):23-39. PubMed ID: 10696568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A recurrent mutation, ala391glu, in the transmembrane region of FGFR3 causes Crouzon syndrome and acanthosis nigricans.
    Wilkes D; Rutland P; Pulleyn LJ; Reardon W; Moss C; Ellis JP; Winter RM; Malcolm S
    J Med Genet; 1996 Sep; 33(9):744-8. PubMed ID: 8880573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A newborn with acanthosis nigricans: can it be Crouzon syndrome with acanthosis nigricans?
    Sharda S; Panigrahi I; Gupta K; Singhi S; Kumar R
    Pediatr Dermatol; 2010; 27(1):43-7. PubMed ID: 20199409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crouzon with acanthosis nigricans. Further delineation of the syndrome.
    Arnaud-López L; Fragoso R; Mantilla-Capacho J; Barros-Núñez P
    Clin Genet; 2007 Nov; 72(5):405-10. PubMed ID: 17935505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mild achondroplasia/hypochondroplasia with acanthosis nigricans, normal development, and a p.Ser348Cys FGFR3 mutation.
    Couser NL; Pande CK; Turcott CM; Spector EB; Aylsworth AS; Powell CM
    Am J Med Genet A; 2017 Apr; 173(4):1097-1101. PubMed ID: 28181399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Crouzon's syndrome with acanthosis nigricans].
    Lapunzina P; Fernández MC; Varela Junquera JM; Arberas C; Tello AM; Gracia Bouthelier R
    An Esp Pediatr; 2002 Apr; 56(4):342-6. PubMed ID: 11927079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expanding the phenotype for the recurrent p.Ala391Glu variant in FGFR3: Beyond crouzon syndrome and acanthosis nigricans.
    Rymer K; Shiang R; Hsiung A; Pandya A; Bigdeli T; Webb BT; Rhodes J
    Mol Genet Genomic Med; 2019 Jun; 7(6):e656. PubMed ID: 31016899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Acanthosis nigricans in children and Crouzon syndrome].
    Lagaude M; Barreau M; Jokic M; Gerard M; DiRocco F; Hadj-Rabia S; Dompmartin A; Verneuil L
    Ann Dermatol Venereol; 2014 Nov; 141(11):685-8. PubMed ID: 25442473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acanthosis nigricans in a boy with achondroplasia due to the classical Gly380Arg mutation in FGFR3.
    Van Esch H; Fryns JE
    Genet Couns; 2004; 15(3):375-7. PubMed ID: 15517832
    [No Abstract]   [Full Text] [Related]  

  • 12. Crouzon syndrome with acanthosis nigricans: case report and mutational analysis.
    Nagase T; Nagase M; Hirose S; Ohmori K
    Cleft Palate Craniofac J; 2000 Jan; 37(1):78-82. PubMed ID: 10670894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crouzonodermoskeletal syndrome.
    Jeftha A; Stephen L; Morkel JA; Beighton P
    J Clin Pediatr Dent; 2004; 28(2):173-6. PubMed ID: 14969379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel skeletal dysplasia with developmental delay and acanthosis nigricans is caused by a Lys650Met mutation in the fibroblast growth factor receptor 3 gene.
    Tavormina PL; Bellus GA; Webster MK; Bamshad MJ; Fraley AE; McIntosh I; Szabo J; Jiang W; Jabs EW; Wilcox WR; Wasmuth JJ; Donoghue DJ; Thompson LM; Francomano CA
    Am J Hum Genet; 1999 Mar; 64(3):722-31. PubMed ID: 10053006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe achondroplasia with developmental delay and acanthosis nigricans (SADDAN): phenotypic analysis of a new skeletal dysplasia caused by a Lys650Met mutation in fibroblast growth factor receptor 3.
    Bellus GA; Bamshad MJ; Przylepa KA; Dorst J; Lee RR; Hurko O; Jabs EW; Curry CJ; Wilcox WR; Lachman RS; Rimoin DL; Francomano CA
    Am J Med Genet; 1999 Jul; 85(1):53-65. PubMed ID: 10377013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prenatal and postnatal presentation of severe achondroplasia with developmental delay and acanthosis nigricans (SADDAN) due to the FGFR3 Lys650Met mutation.
    Zankl A; Elakis G; Susman RD; Inglis G; Gardener G; Buckley MF; Roscioli T
    Am J Med Genet A; 2008 Jan; 146A(2):212-8. PubMed ID: 18076102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An association of acanthosis nigricans and Crouzon syndrome.
    Koizumi H; Tomoyori T; Sato KC; Ohkawara A
    J Dermatol; 1992 Feb; 19(2):122-6. PubMed ID: 1377724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Jugular foraminal stenosis in Crouzon syndrome.
    Martinez-Perez D; Vander Woude DL; Barnes PD; Scott RM; Mulliken JB
    Pediatr Neurosurg; 1996 Nov; 25(5):252-5. PubMed ID: 9309789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical signs, interventions, and treatment course of three different treatment protocols in patients with Crouzon syndrome with acanthosis nigricans.
    de Planque CA; Wall SA; Dalton L; Paternoster G; Arnaud É; van Veelen MC; Versnel SL; Johnson D; Jayamohan J; Mathijssen IMJ
    J Neurosurg Pediatr; 2021 Aug; 28(4):425-431. PubMed ID: 34388723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crouzon with Acanthosis Nigricans and Odontogenic Tumors: A Rare Form of Syndromic Craniosynostosis.
    Xu W; McDonald-McGinn DM; Melchiorre AJ; Zackai EH; Bartlett SP; Taylor JA
    Cleft Palate Craniofac J; 2018 Feb; 55(2):296-300. PubMed ID: 29351036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.